Company intelligence / Profile preview

Sun Biotech Pte Ltd

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

Sun Biotech Pte Ltd specializes in developing high-efficacy and safe vaccines. The company has a robust R&D pipeline targeting infectious diseases such as Zika and rabies, with ongoing collaborations for process development. It supplies vaccines to national immunization programs globally through strong governmental partnerships. Some products may be commercially available while others remain under clinical or preclinical development.

Therapeutic areas: Infectious Diseases
Modalities: Vaccines (including recombinant vaccines)Monoclonal antibodies (e.g., Rabies mAb)
Industry: Biotech

Drug pipeline

1 asset

Hand Foot and Mouth Disease Vaccine (Sun Biotech)

Preclinical

Partnerships

Exothera SA/NV for process development of innovative Zika virus vaccine candidate/process

Beyond the preview

Go deeper on Sun Biotech Pte Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sun Biotech Pte Ltd.

Explore the full profile